Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3745 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 36 37 38  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Univ Manchester–Danaher: mass spectrometer, 201606 supply Sciex Lipidyzer Platform to Stoller Centre 2016-06-13
Bluebird Bio–Lonza: contract manufacturing, 201606– collab long-term commercial manufacturing of Lenti-D + LentiGlobin drug products by Lonza Houston 2016-06-09
CRISPR Therapeutics–Anagenesis: cell therapy, 201606– strategic collab + ww excl license to P2MC technology for cell therapy for muscle diseases 2016-06-08
Sony–Stratec: investment, 201606–201607 acquisition €30m 100% of Sony DADC BioSciences business by Stratec 2016-06-08
F-Star–CMC Biologics: contract manufacturing, 201606– service manufacturing of mAb² bispecific antibodies by CMC Biologics 2016-06-07
Bruker–Scripps Research Institute: mass spectrometry, –201606 collab development of MetaboBASE Personal Library w Center for Metabolomics 2016-06-06
Dr. Falk Pharma–Cosmo Pharmaceuticals: antibiotic, 201606– license existent for Rifamycin SV MMX for EU + Australia 2016-06-06
DSM–Bruker: mass spectrometer, 201606 supply existent DSM Resolve early user of timsTOF system 2016-06-06
Florida State Univ–Bruker: mass spectrometer, 201606 supply existent Prof Bleiholder at Dept Chemistry early user of timsTOF system 2016-06-06
Max Planck–Bruker: mass spectrometer, 201606 supply existent MPI for Biophysics Ffm early user of rapifleX MALDI-TOF/TOF system 2016-06-06
Scripps Research Institute–Bruker: mass spectrometer, 201606 supply existent recently installed impact QTOF system at Center for Metabolomics 2016-06-06
Univ Rouen–Bruker: mass spectrometer, 201606 supply existent Univ Rouen early user of timsTOF system 2016-06-06
Pieris–SEVERAL: investment, 201606 private placement $16.5m w 8.18m units (shares + warrants) at $2.015/unit led by BVF Partners 2016-06-03
Grünenthal–AstraZeneca: lesinurad, 201606– license excl for Europe + Latin America to Zurampic + fixed dose combi of lesinurad + allopurinol 2016-06-02
Thermo Fisher–908 Devices: sample separation technology, 201606 collab integration of ZipChip microfluidics separation with Orbitrap MS systems 2016-06-02
Boehringer–Harvard Univ: drug research, 201606– collab research alliance 3y €na for novel treatments for severe fibrotic diseases 2016-06-01
Celonis–SEVERAL: investment, 201606 financing round Series A $27.5m 2016-06-01
Emperra–Germany (govt): business development, 201606– supply service support in US with German Accelerator Life Sciences programme 2016-06-01
ERS Genomics–MacDougall Biomedical Communications: public relations, 201606 service existent by MacDougall 2016-06-01
TxCell–Univ Lübeck: cell therapy, 201606– collab €na developm of CAR-Treg cells to treat bullous pemphigoid with LIED 2016-06-01
Hyglos–Mérieux: investment, 201605 acquisition 100% of Hyglos by bioMérieux for €24m phased over 3 years 2016-05-31
Link Health–4SC: cancer drug, 201605– collab license + developm partnership for 4SC-205 in Greater China 2016-05-31
Sividon Diagnostics–Myriad: investment, 201605 acquisition for €35m upfront + €15m milestones 2016-05-31
Aleva Neurotherapeutics–SEVERAL: investment, 201605 financing round Series C $18m incl $5m from strategic lead investor Greatbatch Inc 2016-05-27
Qiagen–Therawis: molecular companion diagnostics, 201605– license + co-developm predictive oncology tests w initial project using PITX2 assay 2016-05-25
Axela–Scienion: print/spotting technology, 201605– collab developm + marketing of production systems + services for diagnostics + research 2016-05-24
Epigenomics–SEVERAL: investment, 201605 private placement €6.8m w 1.436m new shares at €4.76/share led by BioChain (55%) 2016-05-24
MorphoSys–Univ Texas: antibody cancer drug, 201605– collab strategic alliance RnD using Ylanthia technology with MD Anderson ORBIT unit 2016-05-24
Xenikos–MC Services: public relations, 201605 service existent for Xenikos BV by MC Services AG Düsseldorf 2016-05-24
Boehringer–BioMed X: pharma research, 201605– collab new BioMed X research group to discover new treatm options for psychiatric diseases 2016-05-23
Univ Birmingham–Bruker: NMR spectrometer, 201605 supply two 600MHz NMR systems w room temperature 5mm probe at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply one Orbitrap Elite MS system w nanoLC + 2D-LC + Advion Triversa Nanomate at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply Q Exactive Plus MS system at Birmingham Metabolomics Training Centre 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply three Q Exactive Focus MS systems w Ultimate3000 RSLC UHPLC systems at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply two Quantiva triple quad MS systems w Ultimate3000 RSLC UHPLC systems at PCB 2016-05-23
Univ Birmingham–United Kingdom (govt): grant, 201411–201605c award £8m for new Phenome Centre Birmingham from MRC + 4 instrument firms + the Univ 2016-05-23
Monsanto–Bayer: investment, 201605– acquisiton unsolicited $66b all-cash offer $128/share by Bayer 2016-05-19
Medigene–BioNTech: cell therapy, 201605– supply + collab process developm to produce TCR-modified T cells by Eufets GmbH 2016-05-18
Bayer–ERS Genomics: CRISPR technology, 201605– license €na to patents for certain cross-divisional applications in Bayer’s core strategic areas 2016-05-17
NousCom–Life Sciences Partners: investment, 201605 financing round Series A totalling €12m co-led by LSP + Versant Ventures 2016-05-17
NousCom–SEVERAL: investment, 201605 financing round Series A €12m co-led by LSP + Versant Ventures 2016-05-17
NousCom–Versant Ventures: investment, 201605 financing round Series A totalling €12m co-led by LSP + Versant Ventures 2016-05-17
Caribou Biosciences–Novartis: investment, 201605 financing round Series B totalling $30m incl existing investor Novartis 2016-05-16
Caribou Biosciences–SEVERAL: investment, 201605 financing round Series B $30m from new + existing investors 2016-05-16
EndoStim–Gimv: investment, 201605 financing round Series D totalling $25m incl $2.7m from Gimv Health & Care 2016-05-12
EndoStim–SEVERAL: investment, 201605 financing round Series D $25m led by Endeavour Vision + incl Santé Ventures + Gimv + Wellington Partners et al 2016-05-12
Boehringer–Max Planck: CNS drug, 201605– Boehringer acquires option for excl rights to new schizophrenia lead compound from LDC 2016-05-11
Bayer–BioNTech: mRNA technology, 201605– collab €na developm mRNA vaccines + therapeutics for animal use 2016-05-10
BioNTech–Bayer: investment, 201605 investment €na by BLSC in connection with animal health mRNA collaboration 2016-05-10
Novimmune–SEVERAL: investment, 201605 financing round CHF30m from existing shareholders 2016-05-10
AC Immune–SEVERAL: investment, 201605 private financing round Series E CHF42.7m 2016-05-09
Expedeon–Genetrix (ES): investment, 201605–201608 acquisition of Expedeon Holdings Ltd by Sygnis AG for €1.7m cash + na shares 2016-05-09
Genetrix (ES)–SEVERAL: investment, 201605–201607 capital increase Sygnis AG €5.3m w 3m rights offering + 1.8m shares private placement €1.1/share 2016-05-09
LabCorp–Epigenomics: molecular diagnostics cancer test, 201605– distribution LabCorp to offer Epi proColon test in the US 2016-05-09
Alrise Biosystems–Creathor Ventures: investment, 201605 existent Alrise listed as current investment on web site of Creathor 2016-05-06
Ayoxxa–Creathor Ventures: investment, 201605 existent Ayoxxa listed as current investment on web site of Creathor 2016-05-06
CAP-CMV GmbH–Creathor Ventures: investment, 201605 existent CAP-CMV listed as current investment on web site of Creathor 2016-05-06
Caprotec–Creathor Ventures: investment, 201605 existent Caprotec listed as current investment on web site of Creathor 2016-05-06
Cevec–Creathor Ventures: investment, 201605 existent Cevec listed as current investment on web site of Creathor 2016-05-06
Chundsell Medicals–Creathor Ventures: investment, 201605 existent Chundsell listed as current investment on web site of Creathor 2016-05-06
Cube Biotech–Creathor Ventures: investment, 201605 existent Cube Biotech listed as current investment on web site of Creathor 2016-05-06
Klara–Creathor Ventures: investment, 201605 existent Klara listed as current investment on web site of Creathor 2016-05-06
Phenex–Creathor Ventures: investment, 201605 existent Phenex listed as current investment on web site of Creathor 2016-05-06
Sirion Biotech–Creathor Ventures: investment, 201605 existent Sirion Biotech listed as current investment on web site of Creathor 2016-05-06
Sividon Diagnostics–Creathor Ventures: investment, 201605 existent Sividon listed as current investment on web site of Creathor 2016-05-06
Euticals–Albany Molecular: investment, 201604–201607 acquisition €315m in cash + stock + a seller note of Prime European Therapeuticals SpA by AMRI 2016-05-05
TU Munich–Werner Siemens Foundation: grant, 201605– donation €11.5m to promote synthetic biotechnology in new TUM School of Bioengineering 2016-05-04
Vaximm–MC Services: public relations, 201605 service existent for Vaximm by MC Services AG 2016-05-04
Ideaya Biosciences–Novartis: investment, 201605 financing round Series A totalling $46m including investor Novartis Institute of Biomedial Research 2016-05-03
Ideaya Biosciences–SEVERAL: investment, 201605 financing round Series A $46m from 5AM Ventures + Canaan Ventures + NIBR et al 2016-05-03
IMS Health–Quintiles: investment, 201603–201610 merger $10.4b into Quintiles IMS w former IMS owners holding 51.4% after merger 2016-05-03
Eppendorf–Bio-ITech: bioinformatics, 201605 collab product integration of eLabJournal ELN with Eppendorf instruments shown at Analytica 2016 2016-05-02
Roche–Evotec: drug discovery services, 201605–201904 collab extension for 3 years discovery small molecule drugs for Genentech 2016-05-01
Bentekk–Hamburg (govt): investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Bentekk–High-Tech Gründerfonds: investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Bentekk–SEVERAL: investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Wilex–SEVERAL: investment, 201604 capital increase €4.13m with 2.25m new shares at €1.84/share whereof >50% to Dievini Hopp 2016-04-25
F-Star–Hume Brophy: public relations, 201604 service existent by Hume Brophy London 2016-04-21
G-Therapeutics–Gimv: investment, 201604 financing round Series A totalling €26m incl co-investor Gimv 2016-04-19
Hopp Group–Promethera: investment, 201604 acquisition of key assets of Cytonet in shares w Hopp family holding up to 13% of Promethera afterwards 2016-04-18
Promethera–Hopp Group: investment, 201604 Hopp family holding up to 13% of Promethera after sale of key assets of Cytonet to Promethera 2016-04-18
Cunesoft–Bavaria (govt): investment, 201604 financing round Series A 7-digit €na incl returning co-investor Bayern Kapital 2016-04-07
Cunesoft–High-Tech Gründerfonds: investment, 201604 financing round Series A 7-digit €na incl returning co-investor HTGF 2016-04-07
Cunesoft–Occident Group: investment, 201604 financing round Series A 7-digit €na incl new + lead investor Occident Group AG 2016-04-07
Cunesoft–SEVERAL: investment, 201604 financing round Series A 7-digit €na led by Occident Group + incl HTGF + Bayern Kapital 2016-04-07
NEO New Oncology–Siemens: investment, 201603 acquisiton by Siemens Healthcare GmbH 2016-03-31
Labiotech.eu–WestTech Ventures: investment, 201602 seed financing round totalling low €6-digit incl lead investor WestTech Ventures 2016-02-03
Novimmune–SEVERAL: investment, 201601 financing round CHF30m from existing shareholders 2016-01-11
Amgen–Biocartis: molecular companion diagnostics, 201712– collab €na developm liquid biopsy Idylla RAS CDx test for Vectibix 2016-01-07
Mecuris–Bavaria (govt): investment, 2016c seed financing round from Bayern Kapital + HTGF 2016-01-01
Mecuris–High-Tech Gründerfonds: investment, 2016c seed financing round from Bayern Kapital + HTGF 2016-01-01
Mecuris–SEVERAL: investment, 2016c seed financing round from Bayern Kapital + HTGF 2016-01-01
Merus–Minapharm: GlymaxX technology, 2016– non-excl license agreem for use of GlymaxX for Biclonics pipeline from ProBioGen AG 2016-01-01
MicrobeDx–Microfluidic ChipShop: microfluidics technology, 2016– collab developm + production of pharmacodiagnostic test systems 2016-01-01
Probiodrug–Crossbeta Biosciences: biomarker research, 2016– collab developm Alzheimer biomarker to support Probiodrug’s clinical AD program 2016-01-01
Storm Therapeutics–Evotec: drug discovery services, 2016– supply service HTS + structural biology to identify hits for 2 RNA modulating targets 2016-01-01
Mologen–Bâloise: investment, 201512 existing investor Bâloise Holding holding estimated 6% in Mologen 2015-12-31
Mologen–Deutsche Balaton: investment, 201512 existing investor holding estimated 5% in Mologen 2015-12-31
Mologen–Global Derivative Trading: investment, 201512 existing investor Global Derivative Trading GmbH owns estimated 24% in Mologen 2015-12-31
Mologen–Salvator Vermögensverwaltungs GmbH: investment, 201512 existing investor holding estimated 5% in Mologen 2015-12-31
next pagenext page 1 2 3 ... 36 37 38  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

» top